Indonesia Pharma up
May 2, 2014
THE Indonesian pharmaceutical
market value will climb from
approximately $5b in 2013 to $9.9b
by 2020, at a compound annual
growth rate of 10.2%, research and
consulting firm GlobalData said.
Driven by increased government
healthcare spending and an
increase in life expectancy, the
majority of the growth comes from
patented drugs, according to the
report.
However, GlobalData Healthcare
Industry Dynamics director Joshua
Owide said the country’s regulatory
system for Intellectual Property
enforcement was problematic
on a number of levels, due to
inadequate observation and
enforcement, and the lack of an
effective customs record system
to discourage infringement of IP
rights.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 May 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 May 14